Trasylol Plaintiffs Step Up Fight To See Bayer Report

Law360, New York (July 14, 2009, 12:00 AM EDT) -- Plaintiffs in the multidistrict litigation over Bayer AG's Trasylol have intensified efforts to obtain an internal report that allegedly discusses dangers associated with the blood-clotting drug.

On Monday, the plaintiffs urged Judge Donald M. Middlebrooks of the U.S. District Court for the Southern District of Florida to force Bayer to relinquish a voluminous report prepared by Dr. Kuno Sprenger, who examined the safety of Trasylol in the so-called i3 study.

Sprenger was suspended from his job duties after failing to disclose the results of the i3...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.